Orchid
Year2023
RoundSeries A
Amount$12M
Overall
Summary
11 slides
11 slides
1 slide
Orchid helps families have healthy babies through advanced genetic testing.
1 slide
Julia and Dan's Embryo Report provides comprehensive genetic information to assist in the decision-making process during IVF, allowing individuals to confer with a genetics expert.
1 slide
IVF creates multiple embryos, and Orchid helps identify the one with the fewest genetic risks by analyzing cell samples from each embryo.
1 slide
Orchid offers the most advanced embryo screening, analyzing 100 times more genetic data than traditional methods. This ensures over 99% genome coverage, compared to less than 1% by other tests.
3 slides
Orchid's panels include: the Neurodevelopmental Disorders (NDD) Panel screening 230+ genes, the Birth Defects Panel screening 900+ genes, and the Hereditary Cancer Panel screening 90+ genes.
1 slide
Genetic counselors explain the results of the 30x Whole Genome Embryo Reports, helping parents understand each embryo's genetic information.
1 slide
Orchid is backed by top embryologists and experts, such as Barry Behr and Jacques Cohen, who endorse our advancements in genetic screening.
1 slide
World-class geneticists, like George Church from Harvard Medical School, support Orchid for its ability to read over 99% of an embryo's DNA and empower families with critical health information.
1 slide
Orchid maximizes the chance of a successful pregnancy and a healthy child, offering superior results for various genetic conditions, outperforming alternatives in accuracy and scope.
